HHS and the Department of Defense (DoD) jointly announced a $12.7 million contract to increase domestic production for two rapid point-of-care COVID-19 tests.
The contract is with InBios...
FDA recently published a list of 223 essential medicines, medical countermeasures, critical inputs to have available at all times and serve patient needs in the appropriate dosage forms.
The product...
Last week, states began to report what communities they will distribute Abbott’s BinaxNOW COVID-19 test to assist ongoing reopening efforts.
Back in August, the Trump Administration announced it...
HHS and the Department of Defense (DoD) recently announced an agreement with Eli Lilly and Company to purchase the first doses of the company’s COVID-19 antibody therapeutic, LY-CoV555.
The...
HHS recently issued guidance authorizing qualified pharmacy technicians and state-authorized pharmacy interns to administer childhood vaccines, COVID-19 vaccines, and COVID-19 tests.
The guidance,...
HHS recently announced that American hospitals can go back to purchasing Gilead’s COVID-19 antiviral, Veklury (remdesivir), directly from the drug’s distributor starting.
Over the...
HHS and The Rockefeller Foundation recently signed an agreement to identify and share effective approaches for increasing rapid point-of-care (POC) COVID-19 testing in various communities.
Under...
HHS recently announced that the CDC will provide $200 million to 64 jurisdictions for COVID-19 vaccine preparedness.
CDC will award the funding from the Coronavirus Aid, Relief, and...
The FDA recently finalized a rule that would allow prescription drug importation from Canada in FDA-authorized programs.
The final rule, part of the White House’s Safe Importation Action Plan,...
HHS and the Department of Defense (DoD) released two documents Wednesday outlining the Trump Administration’s COVID-19 vaccine distribution strategy.
The documents provide four necessary tasks...
Last week, HHS issued guidance under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to safe and effective COVID-19 vaccines when they become available.
The...
Today, CMS issued a proposed rule that would create a new, accelerated Medicare coverage process for innovative products that FDA deems “breakthrough,” including new implants or gene-based...
HHS recently issued a third amendment to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to lifesaving childhood vaccines during the COVID-19...
HHS and the Department of Defense (DoD) recently announced that McKesson Corporation will be a central distributor of future COVID-19 vaccines and related supplies needed to administer the drug.
For...
HHS and the Department of Defense (DoD) recently announced an agreement with Moderna to manufacture and deliver 100 million doses of the company’s COVID-19 vaccine candidate.
For more...
A bipartisan multistate coalition recently called on HHS, the National Institutes of Health (NIH), and FDA urging them to use their authority to increase the availability of remdesivir.
For more...
Twenty-four members of Congress demand increased oversight and transparency of Operation Warp Speed vaccine development program in an official letter to HHS Secretary Alex Azar.
In the letter, the...
The Trump administration is aiming to lower drug prices by eliminating kickbacks to middlemen, like pharmacy benefit managers (PBMs), and increasing drug importation in three new executive orders...
HHS and the Department of Defense (DoD) recently announced an agreement with Pfizer Inc. for large-scale production and nationwide delivery of 100 million doses of its COVID-19 vaccine in the US.
For...
GSK and CureVac recently announced a collaboration for the research, development, manufacturing, and commercialization of five mRNA-based vaccines and monoclonal antibodies (mAbs) targeting infectious...
